Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrea S. James currently holds 201,231 shares of Oncocyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrea S. James has been a net neutral trader of OCX stock. They have purchased $0 and sold $0 worth of shares.
Andrea S. James's most recent insider trade was on Oct 31, 2025, when they sold 50,000 shares at $0.00 per share.
Andrea S. James serves as Executive at Oncocyte Corp (OCX). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Andrea S. James holds the position of Executive at Oncocyte Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Andrea S. James has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andrea S. James was on Oct 31, 2025, when they sold $73.2K worth of IMDX shares. This transaction involved 12,175 shares at $6.01 per share.
Andrea S. James currently owns 201,231 shares of Oncocyte Corp (OCX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrea S. James's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrea S. James has 7 Form 4 filings on record as an insider at Oncocyte Corp.
Set alerts for Andrea S. James and 40,000+ other insiders.